Skip to main content
Book cover

Congenital Abnormalities and Preterm Birth Related to Maternal Illnesses During Pregnancy

  • Book
  • © 2010

Overview

  • uniquely large database
  • systematic analysis of maternal diseases
  • recommendations for future studies

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 219.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (20 chapters)

  1. The Study Population and Methods

  2. Results of Studies and Their Interpretation

Keywords

About this book

The major objective of our studies in the last decade was a systematic analysis of maternal diseases during pregnancy to reveal their possible adverse effects on birth outcomes. The two most important factors of infant mortality were parti- larly analyzed: structural birth defects, known as congenital abnormalities (CAs) and preterm birth (PB). In general the objectives of scienti c studies might be either to test a new hypothesis or to con rm or confront previously published results. However, less frequently the authors/scientists have personal motivations determined by their professional activities. The authors of this book are practicing physicians and genetic epidemiologist who are mainly interested in the following three practical questions: 1. The possible adverse effects of pharmaceutical products. The possible t- atogenic potential of about 170 drugs has been evaluated very thoroughly using the data set of the Hungarian Case-Control Surveillance of Congenital Abnormalities (HCCSCA) in the last 50 years. These drugs were used to treat maternal diseases and the ndings of our population-based case-control studies will be cited in this book and are shown in the Appendix at the end of the book. However, our long experiences showed two problems in the drug teratology. In general the evaluation of clinical doses of these drugs is a particularly dif- cult challenge due to the modi cation effects of confounders. This problem motivated one of the authors to establish a new model of disaster epidemiology.

Reviews

From the reviews:

“In this presentation of the Hungarian Congenital Abnormality Registry, the authors use a large case-control analysis to determine the risk of pregnancy malformations in a variety of maternal conditions. … The audience includes obstetricians or practitioners involved in high-risk obstetrics. … This is an ambitious presentation of one country’s risk of congenital abnormalities and preterm birth.” (Anthony Shanks, Doody’s Review Service, October, 2010)

Editors and Affiliations

  • , Second Department of Obstetrics and Gyne, Semmelweis University, Budapest, Hungary

    Nándor Ács

  • Second Department of Obstetrics and Gyne, Semmelweis University, Budapest, Hungary

    Ferenc G. Bánhidy

  • Hereditary Diseases, Foundation f. Community Control of, Budapest, Hungary

    Andrew E. Czeizel

Bibliographic Information

Publish with us